Bitte das Formular ausfüllen, um das Webinar freizuschalten

Vorname

Nachname

Unternehmens-E-Mail-Adresse

Unternehmen

Rolle

Telefonnummer

Durch Klick auf die Schaltfläche akzeptierst du unsere Nutzungsbedingungen, unsere Datenschutzrichtlinie und die Speicherung deiner Daten in den USA.

Teile dieses Webinar

Schließe deine Daten- und KI-Kompetenzlücke

Wir sind die einzige Plattform, die speziell dafür entwickelt wurde, Daten- und KI-Kompetenzen in Ihrer gesamten Organisation voranzubringen. Lassen Sie uns ein maßgeschneidertes Programm erkunden.

Enterprise-Demo Buchen

Ein kleines Team weiterbilden?Jetzt loslegen

Artificial Intelligence

Cutting Through the Hype: An Insider’s Account of AI in Healthcare

November 2021

Ihre Präsentator(en)

Hugo Bowne-Anderson

Data Scientist

Arnaub Chatterjee

Arnaub is a Senior Expert/Associate Partner in the Pharmaceutical and Medical Products group at McKinsey & Company. Additionally, he serves as Teaching Associate in the Department of Health Care Policy at Harvard Medical School and Lecturer in the Department of Policy Analysis and Management at Cornell University. At McKinsey, he advises pharmaceutical and biotech companies on a range of topics, including digital transformation, utilizing novel data and analytics for product positioning and preparing for launch. He also works with leading technology companies and startups who are entering the healthcare sector on a range of market strategy and entry issues.

Prior to McKinsey, he served as Director within Merck's Data Science and Insights group where he led ventures and partnerships with academic medical centers, payers and technology companies to power R&D and commercial activities. He previously served in the Obama Administration as an advisor to former Chief Technology Officers Todd Park and Bryan Sivak at the U.S. Department of Health and Human Services (HHS). At HHS, he co-led efforts for the Health Data Initiative, designed the www.healthdata.gov platform, and launched the Innovation Fellows Program. At HHS, he also worked in the Secretary's Office as a lead policy analyst on healthcare fraud and abuse policy initiatives around the Affordable Care Act. Prior to government service, he spent a number of years as a strategy consultant at Deloitte Consulting, supporting pharmaceutical companies on M&A strategy.

He holds graduate degrees in health administration (MHA) and public administration (MPA) from Cornell University and received his undergraduate degree from the University of Michigan.

Summary

AI and machine learning are reshaping the healthcare sector by simplifying administrative tasks, enhancing diagnostic accuracy, and speeding up drug discovery. Despite the excitement around it, there are significant achievements, especially in diagnostic imaging, where AI has shown potential in boosting productivity and accuracy. Both startups and tech giants are investigating the potential of AI, with significant projects such as Google's diabetic retinopathy prediction and Facebook's Fast MRI initiative. However, challenges persist, including the reproducibility of algorithms, the need for standardized data, and ethical considerations. Regulatory bodies are beginning to address these challenges by setting guidelines for AI applications in healthcare. The potential for AI to revolutionize healthcare is vast, but it requires cooperation across various stakeholders to ensure ethical and effective implementation.

Key Takeaways:

AI is making significant progress in diagnostic imaging, with projects like Google's diabetic retinopathy prediction outperforming human experts.
Regulatory bodies are starting to approve AI algorithms for medical use, but consistency and transparency remain challenges.
Ethical considerations are essential, as AI applications in healthcare can have significant implications for patient care.
Standardization and quality of data are vital for the successful implementation of AI in healthcare.
Cooperation between tech companies, healthcare providers, and regulatory bodies is necessary to fully utilize the potential of AI in healthcare.

Deep Dives

AI in Diagnostic Imaging

Diagnostic imaging is one of the most promising areas for AI application in healthcare. With hospitals producing large amounts of imaging data annually, AI's ability to boost productivity and accuracy is invaluable. Google Brain's work on diabetic retinopathy demonstrates AI's potential, as their convolutional neural network outperformed a panel of ophthalmologists. This success marks the start of AI's transformative impact on diagnostic imaging, with potential applications in dermatology and pathology. The availability of medical imaging data and compelling use cases make this an excellent area for AI innovation.

Regulatory Challenges and Ethical Considerations

The implementation of AI in healthcare comes with challenges, particularly regarding regulation and ethics. The opaque nature of many AI algorithms complicates their transparency and accountability. Regulatory bodies like the FDA are beginning to establish guidelines for AI applications, approving algorithms for specific medical uses. However, the lack of consistency and standardization in data remains a significant hurdle. Ethical considerations are also vital, as AI's role in healthcare can have profound implications for patient outcomes. Ensuring that AI applications adhere to ethical guidelines and are developed transparently is essential for their successful integration into healthcare.

Data Standardization and Quality

Standardization and quality of data are vital for the successful implementation of AI in healthcare. The lack of standardized data formats and the inconsistency of data quality pose significant challenges. Initiatives like HL7's FHIR standards aim to create a consistent data framework, promoting interoperability and reducing data silos. These efforts are necessary for enabling AI algorithms to access reliable and comprehensive datasets, which are vital for training and validating AI models. As healthcare organizations strive to implement AI solutions, addressing these data challenges is essential.

Collaboration and Innovation in AI Healthcare

Cooperation across various stakeholders is necessary to fully utilize the potential of AI in healthcare. Tech companies, healthcare providers, regulatory bodies, and academic institutions must work together to develop and implement AI solutions that are ethical, effective, and beneficial to patient care. Startups like Benevolent AI and collaborations between tech giants and healthcare institutions illustrate the innovative partnerships driving AI advancements. By encouraging a collaborative environment and supporting cross-disciplinary partnerships, the healthcare industry can overcome the challenges associated with AI implementation and unlock its transformative potential.